A huge study in Israel found that the vaccine reduced symptomatic cases by 94 percent a week after the second dose, and reduced severe disease by 92 percent. Source: New York Times
0
0
Happy
0 %
Sad
0 %
Excited
0 %
Sleppy
0 %
Angry
0 %
Surprise
0 %
